Product Name |
CARBIDOPA 50 MG +LEVODOPA 200MG TABLET |
Packing |
10X10 TABLET |
Available strength |
50 MG +200MG |
Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson’s disease, postencephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.